Cooper Companies Inc
COO81.325USD
-0.345-0.42%
Horário de mercado （ET）Cotações atrasadas em 15 min
16.26BValor de mercado
39.14P/L TTM
Mais detalhes de Cooper Companies Inc Empresa
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Informações da empresa
Código da empresaCOO
Nome da EmpresaCooper Companies Inc
Data de listagemJan 21, 1983
Fundado em1980
CEOMr. Albert G. White, III
Número de funcionários16000
Tipo de títulosOrdinary Share
Fim do ano fiscalJan 21
Endereço6101 Bollinger Canyon Road
CidadeSAN RAMON
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94583
Telefone19254603600
Sitehttps://www.coopercos.com/
Código da empresaCOO
Data de listagemJan 21, 1983
Fundado em1980
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Robert S. (Bob) Weiss
Mr. Robert S. (Bob) Weiss
Independent Chairman of the Board
Independent Chairman of the Board
554.31K
+0.54%
Mr. Daniel G. (Dan) Mcbride, Esq.
Mr. Daniel G. (Dan) Mcbride, Esq.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
154.62K
+7.82%
Ms. Holly R. Sheffield
Ms. Holly R. Sheffield
President - CooperSurgical, Inc
President - CooperSurgical, Inc
37.82K
+32.55%
Ms. Colleen E. Jay
Ms. Colleen E. Jay
Independent Director
Independent Director
29.52K
+10.15%
Ms. Teresa Smith Madden
Ms. Teresa Smith Madden
Independent Director
Independent Director
12.01K
+29.30%
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Independent Director
Independent Director
10.14K
+36.67%
Ms. Cynthia L. (Cindy) Lucchese, CPA
Ms. Cynthia L. (Cindy) Lucchese, CPA
Independent Director
Independent Director
7.66K
+55.08%
Mr. Agostino Ricupati
Mr. Agostino Ricupati
Senior Vice President - Finance and Tax, Chief Accounting Officer
Senior Vice President - Finance and Tax, Chief Accounting Officer
7.51K
+15.72%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Director
Independent Director
3.78K
+257.67%
Mr. Nicholas S. Khadder, J.D.
Mr. Nicholas S. Khadder, J.D.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
2.14K
+320.67%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Robert S. (Bob) Weiss
Mr. Robert S. (Bob) Weiss
Independent Chairman of the Board
Independent Chairman of the Board
554.31K
+0.54%
Mr. Daniel G. (Dan) Mcbride, Esq.
Mr. Daniel G. (Dan) Mcbride, Esq.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
154.62K
+7.82%
Ms. Holly R. Sheffield
Ms. Holly R. Sheffield
President - CooperSurgical, Inc
President - CooperSurgical, Inc
37.82K
+32.55%
Ms. Colleen E. Jay
Ms. Colleen E. Jay
Independent Director
Independent Director
29.52K
+10.15%
Ms. Teresa Smith Madden
Ms. Teresa Smith Madden
Independent Director
Independent Director
12.01K
+29.30%
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Independent Director
Independent Director
10.14K
+36.67%
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Sphere, other
326.70M
33.87%
Toric and multifocal
319.40M
33.11%
Office and surgical procedures
198.90M
20.62%
Fertility
119.70M
12.41%
Por RegiãoUSD
Nome
Receita
Proporção
United States
496.40M
51.46%
Europe
287.50M
29.80%
Rest of the World
180.80M
18.74%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Sphere, other
326.70M
33.87%
Toric and multifocal
319.40M
33.11%
Office and surgical procedures
198.90M
20.62%
Fertility
119.70M
12.41%
Acionista
Tempo de atualização: sex, 21 de fev
Tempo de atualização: sex, 21 de fev
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
The Vanguard Group, Inc.
11.88%
BlackRock Institutional Trust Company, N.A.
4.96%
State Street Global Advisors (US)
4.34%
Kayne Anderson Rudnick Investment Management, LLC
4.04%
T. Rowe Price Investment Management, Inc.
3.84%
Other
70.93%
Estatísticas dos acionistas
Acionista
Proporção
The Vanguard Group, Inc.
11.88%
BlackRock Institutional Trust Company, N.A.
4.96%
State Street Global Advisors (US)
4.34%
Kayne Anderson Rudnick Investment Management, LLC
4.04%
T. Rowe Price Investment Management, Inc.
3.84%
Other
70.93%
Tipo
Acionista
Proporção
Investment Advisor/Hedge Fund
47.72%
Investment Advisor
40.93%
Hedge Fund
3.27%
Research Firm
3.13%
Pension Fund
1.69%
Bank and Trust
1.30%
Sovereign Wealth Fund
1.25%
Family Office
0.94%
Family Office
0.91%
Participação acionária institucional
Tempo de atualização: seg, 20 de jan
Tempo de atualização: seg, 20 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
1356
200.64M
100.33%
-1.44M
2024Q4
1374
201.70M
100.87%
-2.46M
2024Q3
1342
195.61M
98.22%
-9.91M
2024Q2
1326
197.76M
99.32%
-3.35M
2024Q1
1322
193.10M
97.16%
-14.36M
2023Q4
1307
199.91M
100.91%
-7.12M
2023Q3
1298
198.32M
100.11%
-6.24M
2023Q2
1283
197.41M
99.69%
-11.80M
2023Q1
1278
201.66M
101.94%
-5.00M
2022Q4
1271
200.40M
101.51%
-5.00M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
23.76M
11.88%
-37.32K
-0.16%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
9.92M
4.96%
-10.20K
-0.10%
Dec 31, 2024
State Street Global Advisors (US)
8.68M
4.34%
+92.96K
+1.08%
Dec 31, 2024
Kayne Anderson Rudnick Investment Management, LLC
8.08M
4.04%
+2.24K
+0.03%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
7.68M
3.84%
+155.23K
+2.06%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.91M
2.45%
+109.91K
+2.29%
Dec 31, 2024
AllianceBernstein L.P.
4.53M
2.27%
-521.42K
-10.32%
Dec 31, 2024
Victory Capital Management Inc.
4.53M
2.26%
+574.90K
+14.55%
Dec 31, 2024
Capital World Investors
4.19M
2.09%
-232.24K
-5.25%
Dec 31, 2024
Veritas Asset Management LLP
4.05M
2.03%
-355.06K
-8.05%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
Goldman Sachs Future Health Care Equity ETF
3.93%
Motley Fool Mid-Cap Growth ETF
2.5%
Congress SMid Growth ETF
1.98%
Harbor Health Care ETF
1.66%
SPDR S&P Health Care Equipment ETF
1.63%
Invesco ESG NASDAQ Next Gen 100 ETF
1.48%
Invesco S&P 500 Equal Weight Health Care ETF
1.44%
Goldman Sachs Future Consumer Equity ETF
1.23%
First Trust Indxx Medical Devices ETF
1.14%
Invesco NASDAQ Next Gen 100 ETF
1.04%
Ver Mais
Goldman Sachs Future Health Care Equity ETF
Proporção3.93%
Motley Fool Mid-Cap Growth ETF
Proporção2.5%
Congress SMid Growth ETF
Proporção1.98%
Harbor Health Care ETF
Proporção1.66%
SPDR S&P Health Care Equipment ETF
Proporção1.63%
Invesco ESG NASDAQ Next Gen 100 ETF
Proporção1.48%
Invesco S&P 500 Equal Weight Health Care ETF
Proporção1.44%
Goldman Sachs Future Consumer Equity ETF
Proporção1.23%
First Trust Indxx Medical Devices ETF
Proporção1.14%
Invesco NASDAQ Next Gen 100 ETF
Proporção1.04%
Dividendo
Um total de
12.00M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jul 12, 2023
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2023 going ex on Jul 26, 2023
Jul 27, 2023
Aug 11, 2023
Jul 26, 2023
Dec 14, 2022
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 10, 2023 going ex on Jan 20, 2023
Jan 23, 2023
Feb 10, 2023
Jan 20, 2023
Jul 13, 2022
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2022 going ex on Jul 26, 2022
Jul 27, 2022
Aug 11, 2022
Jul 26, 2022
Dec 08, 2021
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 09, 2022 going ex on Jan 20, 2022
Jan 21, 2022
Feb 09, 2022
Jan 20, 2022
Jul 14, 2021
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2021 going ex on Jul 26, 2021
Jul 27, 2021
Aug 11, 2021
Jul 26, 2021
Jan 07, 2021
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 09, 2021 going ex on Jan 21, 2021
Jan 22, 2021
Feb 09, 2021
Jan 21, 2021
Jul 09, 2020
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 07, 2020 going ex on Jul 22, 2020
Jul 23, 2020
Aug 07, 2020
Jul 22, 2020
Jan 07, 2020
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 10, 2020 going ex on Jan 22, 2020
Jan 23, 2020
Feb 10, 2020
Jan 22, 2020
Desdobramento de ações
Data
Tipo
Proporção
Dec 07, 2023
Split
1>4
Data
Tipo
Proporção
Dec 07, 2023
Split
1>4